Maris JM - Search Results

1

Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastoma.

Krytska K, Casey CE, Pogoriler J, Martinez D, Rathi KS, Farrel A, Berko ER, Tsang M, Sano RR, Kendsersky N, Erickson SW, Teicher BA, Isse K, Saunders L, Smith MA, Maris JM, Mossé YP. Krytska K, et al. Among authors: maris jm. Cancer Res Commun. 2022 Jul;2(7):616-623. doi: 10.1158/2767-9764.crc-22-0137. Epub 2022 Jul 11. Cancer Res Commun. 2022. PMID: 36381237 Free PMC article.

2

Significance of chromosome 1p loss of heterozygosity in neuroblastoma.

Maris JM, White PS, Beltinger CP, Sulman EP, Castleberry RP, Shuster JJ, Look AT, Brodeur GM. Maris JM, et al. Cancer Res. 1995 Oct 15;55(20):4664-9. Cancer Res. 1995. PMID: 7553646

3

No CDKN2 mutations in neuroblastomas.

Beltinger CP, White PS, Sulman EP, Maris JM, Brodeur GM. Beltinger CP, et al. Among authors: maris jm. Cancer Res. 1995 May 15;55(10):2053-5. Cancer Res. 1995. PMID: 7743501

4

Familial predisposition to neuroblastoma does not map to chromosome band 1p36.

Maris JM, Kyemba SM, Rebbeck TR, White PS, Sulman EP, Jensen SJ, Allen C, Biegel JA, Yanofsky RA, Feldman GL, Brodeur GM. Maris JM, et al. Cancer Res. 1996 Aug 1;56(15):3421-5. Cancer Res. 1996. PMID: 8758905

5

Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.

Thompson PM, Maris JM, Hogarty MD, Seeger RC, Reynolds CP, Brodeur GM, White PS. Thompson PM, et al. Among authors: maris jm. Cancer Res. 2001 Jan 15;61(2):679-86. Cancer Res. 2001. PMID: 11212268

6

Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13.

Maris JM, Weiss MJ, Mosse Y, Hii G, Guo C, White PS, Hogarty MD, Mirensky T, Brodeur GM, Rebbeck TR, Urbanek M, Shusterman S. Maris JM, et al. Cancer Res. 2002 Nov 15;62(22):6651-8. Cancer Res. 2002. PMID: 12438263

7

Testing of new agents in childhood cancer preclinical models: meeting summary.

Houghton PJ, Adamson PC, Blaney S, Fine HA, Gorlick R, Haber M, Helman L, Hirschfeld S, Hollingshead MG, Israel MA, Lock RB, Maris JM, Merlino G, Patterson W, Reynolds CP, Shannon K, Yu A, Yu J, Smith MA. Houghton PJ, et al. Among authors: maris jm. Clin Cancer Res. 2002 Dec;8(12):3646-57. Clin Cancer Res. 2002. PMID: 12473573

8

ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.

Wang Q, Hii G, Shusterman S, Mosse Y, Winter CL, Guo C, Zhao H, Rappaport E, Hogarty MD, Maris JM. Wang Q, et al. Among authors: maris jm. Cancer Res. 2003 Apr 1;63(7):1631-5. Cancer Res. 2003. PMID: 12670915

9

Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastoma.

Mosse Y, Greshock J, King A, Khazi D, Weber BL, Maris JM. Mosse Y, et al. Among authors: maris jm. Lancet Oncol. 2003 Dec;4(12):769-71. doi: 10.1016/s1470-2045(03)01283-x. Lancet Oncol. 2003. PMID: 14662434 No abstract available.

10

Detection of single-copy chromosome 17q gain in human neuroblastomas using real-time quantitative polymerase chain reaction.

Morowitz M, Shusterman S, Mosse Y, Hii G, Winter CL, Khazi D, Wang Q, King R, Maris JM. Morowitz M, et al. Among authors: maris jm. Mod Pathol. 2003 Dec;16(12):1248-56. doi: 10.1097/01.MP.0000097364.64566.81. Mod Pathol. 2003. PMID: 14681326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

419 results

Search Page